Ora Biomedical closes funding on mTOR screening project
Rapamycin Longevity Labs and Ora Biomedical have officially reached the funding goal for the largest-ever lifespan analysis of 601 mTOR modulators! This project is driven by Rapamycin The mission is to identify compounds even more potent than Rapamycin in extending lifespan in model animals.